Manhattan Hospital Partners with Cybin to Provide Psychedelic Therapies to Marginalized Communities
“It’s time for psychedelic medicine to climb down from the ivory tower and into the community,” says Cybin Chief Clinical Officer Dr. Alex Belser.
Psychedelic Spotlight News
Does Jon Stewart Microdose Magic Mushrooms? | Plus Pirate Eye
Does Jon Stewart Microdosing Magic Mushrooms?
Have you ever wanted to try microdosing magic mushrooms before, because Jon Stewart wants to! On a recent podcast episode of The Problem with Jon Stewart, the political comedian opened his show by saying “I’ve been microdosing the whole week!”, before clarifying that he just WANTS to try psychedelic microdosing.
The satirist, sometimes known as America’s Conscience, is one of the most influential voices in media over the last 3 decades. His short and funny forrow into the psychedelics debate should help further propel the issue into the mainstream.
Can microdosing help depression? Can Microdosing help mental health? Jon Stewart thinks so, though this claim needs to be verified by the medical establishment.
Microdosing has become a popular trend for professionals in the last few decades, so it is not surprising that Jon Stewart knows about it. He is a man with his finger on America’s pulse.
Link to podcast: https://open.spotify.com/episode/3OZV5DLbn33bNSUluLS7oX?si=qVoGF4cCS76x_MrM9h_slw
Enjoy the episode!
Follow us on social media!
Instagram: @thepsychedelicinvestor
Facebook: @thepsychedelicinvestor
James’ Twitter: @Psy_Invest
Maria’s Twitter (Producer & Editor): @Psy_Holy
Want to collaborate? Send us an email at:
thepsychedelicinvestor@gmail.com
Music from:
www.bensound.com
Video editing: @themyaholy
#jonstweart #thejonsteartproblem #psychedelics
Jon Stewart ‘Would Love’ to Try Microdosing Psychedelics
The comedian publicly expresses interest in the mental health treatment trend the same day as Paul Stamets’ massive microdosing study results were published.
New Evidence Microdosing Psychedelics Reduces Anxiety and Depression
This study also showed microdosers were less likely to use alcohol and were most likely to abstain from consuming alcohol entirely.
A Deep Dive Into MindMed’s Microdosing Program: Project Flow | Plus a NEW LSD Microdosing Study
In today’s episode, we look at MindMed’s (Nasdaq: MNMD, NEO: MMED) Project Flow, which is their LSD microdosing division. At present, MindMed’s microdosing program is split into 2 projects: base testing of LSD microdoses in healthy individuals, and using LSD microdoses to treat adult ADHD.
We will explore the progress made on both fronts, and where the program will expand to in the future, such as psilocybin (magic mushrooms) microdosing.
Ultimately, MindMed wants to answer questions such as:
Can microdosing psychedelics treat ADHD?
Can microdosing LSD improve your concentration?
Can microdosing decrease your anxiety?
Does microdosing increase creativity?
Does microdosing improve your mood?
Recently MindMed announced they are ready to begin recruiting for a study testing the variations in effect when taking LSD microdoses in the morning, compared to at night. The study will also try to answer the last four above questions. We discuss this study extensively.
Links:
MindMed Project Flow: https://mindmed.co/psychedelic-inspired/#scroll_section-2
MindMed New study: https://psilocybinalpha.com/news/mindmed-launches-study-of-low-dose-lsd-effects-on-sleep-and-cognitive-measures
Imperial College of London study: https://www.theguardian.com/science/2021/mar/02/microdosing-lsd-benefits-might-be-placebo-effect-study-finds
Project Albert Quote: https://mindmed.co/news/press-release/mindmed-expands-psychedelic-microdosing-division-adds-groundbreaking-study-evaluating-lsd-microdosing-through-next-gen-digital-clinical-markers/
Kim Kuypers Study: https://www.nature.com/articles/s41598-021-01811-4
MindMed Investor’s Deck: https://mindmed.co/wp-content/uploads/2021/11/MindMed-Presentation-11.17-compressed.pdf
LSD for ADHD: https://mindmed.co/news/press-release/mindmed-advances-phase-2-lsd-microdosing-trial-for-adult-adhd-appoints-principal-investigator/
https://mindmed.co/news/press-release/mindmeds-microdosing-division-further-expands-phase-2-clinical-trial-of-microdosing-lsdfor-adult-adhd/
Previous MindMed LSD study: https://mindmed.co/news/press-release/mindmed-announces-the-completion-of-phase-1-study-measuring-dosing-effects-of-lsd/
Enjoy the episode!
Follow us on social media!
Instagram: @thepsychedelicinvestor
Facebook: @thepsychedelicinvestor
James’ Twitter: @Psy_Invest
Maria’s Twitter (Producer & Editor): @Psy_Holy
Want to collaborate? Send us an email at:
thepsychedelicinvestor@gmail.com
Music from:
www.bensound.com
Video editing: @themyaholy
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.
#Mindmed #MNMDstock #Microdosing
Ayahuasca Helped Will Smith ‘Surrender’ and More Psychedelic Revelations From Actor’s Memoir ‘Will’
“If I’m this beautiful, I don’t need #1 movies to feel good about myself,” Will Smith writes in memoir detailing his first ayahuasca ceremony.
CYBIN CEO Doug Drysdale On How CYB-003 Is Better Than Psilocybin | Next Gen Psychedelics
In this episode of the Spotlight On, James Hallifax from…
How Dr. Monnica Williams Created Canada’s First Psychedelic Master’s Degree Program: ‘Nobody Took Me Seriously’
After two long years of preparing documents and presenting to various committees, the program is in its final stages, and the University of Ottawa will soon begin accepting applications for the fall semester.
Psychedelic Business Spotlight: November 19
This week in psychedelic business news: Companies partner on new dosage method; MindMed investigates LSD microdosing; Health Canada allows a psilocybin production campus.
Jada Pinkett Smith Tackles Exclusion of People of Color From Psychedelic Research on ‘Red Table Talk’
“We know nothing scientific about psychedelics and people of color and how appropriate our treatments are for people in those communities,” says psychedelic researcher Dr. Monnica Wiliams.
End of content
End of content